艾可蓝控股子公司上海燚健携手艾昆纬 共推AI Agent技术赋能医疗健康产业革新

Group 1 - The core collaboration between Shanghai Yijian and IQVIA focuses on the application of AI Agent technology in the healthcare sector, aiming to drive the digital transformation of the industry [1][3][4] - Shanghai Yijian leverages its expertise in digitalization and AI, supported by a team of experienced professionals, to provide practical solutions for the healthcare industry [2][3] - The partnership aims to enhance the efficiency of data-driven decision-making and reshape operational paradigms through generative AI, offering deep industry insights and practical sharing for pharmaceutical companies [2][3] Group 2 - The integration of AI Agent technology is seen as a key engine for upgrading the healthcare industry, facilitating a shift from traditional operational models to intelligent and automated systems [3][4] - The collaboration signifies a strategic breakthrough for Aikelan in diversifying its business into the medical AI field, showcasing the technological capabilities of local enterprises [4] - The ongoing partnership between IQVIA and Shanghai Yijian is expected to contribute to the high-quality development of the healthcare industry by driving innovation and optimizing resource allocation [4]